Gene Biotherapeutics Inc (CRXM)
0.00
USD |
OTCM |
May 17, 16:00
Gene Biotherapeutics Shareholders Equity (Quarterly): -3.718M for March 31, 2017
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2020 | -3.875M |
September 30, 2020 | -3.432M |
June 30, 2020 | -3.071M |
March 31, 2020 | -4.44M |
December 31, 2019 | -4.290M |
March 31, 2017 | -3.718M |
December 31, 2016 | -3.138M |
September 30, 2016 | -2.339M |
June 30, 2016 | -4.550M |
March 31, 2016 | -3.945M |
December 31, 2015 | -3.794M |
September 30, 2015 | -3.362M |
June 30, 2015 | -2.873M |
March 31, 2015 | -2.174M |
December 31, 2014 | -1.682M |
September 30, 2014 | -0.3417M |
June 30, 2014 | 1.099M |
March 31, 2014 | 0.7103M |
December 31, 2013 | 1.185M |
September 30, 2013 | 3.950M |
June 30, 2013 | 4.253M |
March 31, 2013 | 4.210M |
December 31, 2012 | 6.366M |
September 30, 2012 | 8.284M |
June 30, 2012 | 8.120M |
Date | Value |
---|---|
March 31, 2012 | 9.997M |
December 31, 2011 | 6.085M |
September 30, 2011 | 2.511M |
June 30, 2011 | 4.058M |
March 31, 2011 | 5.762M |
December 31, 2010 | 7.428M |
September 30, 2010 | 4.611M |
June 30, 2010 | 7.580M |
March 31, 2010 | 7.310M |
December 31, 2009 | -2.155M |
September 30, 2009 | -17.61M |
June 30, 2009 | -29.55M |
March 31, 2009 | -18.53M |
December 31, 2008 | -0.7548M |
September 30, 2008 | 1.476M |
June 30, 2008 | 4.104M |
March 31, 2008 | 7.175M |
December 31, 2007 | 8.428M |
September 30, 2007 | 14.70M |
June 30, 2007 | 20.20M |
March 31, 2007 | 26.09M |
December 31, 2006 | 11.15M |
September 30, 2006 | 17.24M |
June 30, 2006 | 22.20M |
March 31, 2006 | 25.34M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-4.44M
Minimum
Mar 2020
-3.071M
Maximum
Jun 2020
-3.822M
Average
-3.875M
Median
Dec 2020
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 10.23M |
Perspective Therapeutics Inc | 229.89M |
Protalix BioTherapeutics Inc | 29.79M |
Electromed Inc | 42.54M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.3739M |
Total Liabilities (Quarterly) | 4.092M |